Eosinophils in mucosal immune responses

[1]  K. Nadeau,et al.  Intravenous anti-IL-13 mAb QAX576 for the treatment of eosinophilic esophagitis. , 2015, The Journal of allergy and clinical immunology.

[2]  Eh Lee,et al.  IL-1β in eosinophil-mediated small intestinal homeostasis and IgA production , 2014, Mucosal Immunology.

[3]  W. Busse,et al.  Benralizumab, an anti-interleukin 5 receptor α monoclonal antibody, versus placebo for uncontrolled eosinophilic asthma: a phase 2b randomised dose-ranging study. , 2014, The Lancet. Respiratory medicine.

[4]  A. Bredenoord,et al.  GWAS identifies four novel eosinophilic esophagitis loci , 2014, Nature Communications.

[5]  Ian D Pavord,et al.  Mepolizumab treatment in patients with severe eosinophilic asthma. , 2014, The New England journal of medicine.

[6]  James J. Lee,et al.  Eosinophil-mediated signalling attenuates inflammatory responses in experimental colitis , 2014, Gut.

[7]  I. Pavord,et al.  Oral glucocorticoid-sparing effect of mepolizumab in eosinophilic asthma. , 2014, The New England journal of medicine.

[8]  F. Clayton,et al.  Eosinophilic esophagitis in adults is associated with IgG4 and not mediated by IgE. , 2014, Gastroenterology.

[9]  M. Jordana,et al.  Indigenous enteric eosinophils control DCs to initiate a primary Th2 immune response in vivo , 2014, The Journal of experimental medicine.

[10]  Andrew M. Rupert,et al.  Genome-wide association analysis of eosinophilic esophagitis provides insight into the tissue specificity of this allergic disease , 2014, Nature Genetics.

[11]  R. Palmiter,et al.  Eosinophils and Type 2 Cytokine Signaling in Macrophages Orchestrate Development of Functional Beige Fat , 2014, Cell.

[12]  G. Gleich,et al.  Electron microscopy elucidates eosinophil degranulation patterns in patients with eosinophilic esophagitis. , 2014, The Journal of allergy and clinical immunology.

[13]  L. Boulet,et al.  Effects of an anti-TSLP antibody on allergen-induced asthmatic responses. , 2014, The New England journal of medicine.

[14]  Lisa J. Martin,et al.  Increased Prevalence of Eosinophilic Gastrointestinal Disorders in Pediatric PTEN Hamartoma Tumor Syndromes , 2014, Journal of pediatric gastroenterology and nutrition.

[15]  M. Raffeld,et al.  The eosinophil surface receptor epidermal growth factor-like module containing mucin-like hormone receptor 1 (EMR1): a novel therapeutic target for eosinophilic disorders. , 2014, The Journal of allergy and clinical immunology.

[16]  E. Fiebiger,et al.  Involvement of the iNKT Cell Pathway Is Associated With Early-Onset Eosinophilic Esophagitis and Response to Allergen Avoidance Therapy , 2014, The American Journal of Gastroenterology.

[17]  C. Berek,et al.  Eosinophils promote generation and maintenance of immunoglobulin-A-expressing plasma cells and contribute to gut immune homeostasis. , 2014, Immunity.

[18]  James J. Lee,et al.  Eosinophils Regulate Peripheral B Cell Numbers in Both Mice and Humans , 2014, The Journal of Immunology.

[19]  W. Grady,et al.  Inactivation of TGF-β signaling and loss of PTEN cooperate to induce colon cancer in vivo , 2014, Oncogene.

[20]  Paige Lacy,et al.  Eosinophil activities modulate the immune/inflammatory character of allergic respiratory responses in mice , 2014, Allergy.

[21]  S. Miehlke.  Clinical Features of Eosinophilic Esophagitis , 2014, Digestive Diseases.

[22]  W. Zwart,et al.  Desmoglein-1 regulates esophageal epithelial barrier function and immune responses in eosinophilic esophagitis , 2013, Mucosal Immunology.

[23]  Steffen Jung,et al.  Paired immunoglobulin-like receptor A is an intrinsic, self-limiting suppressor of IL-5-induced eosinophil development , 2013, Nature Immunology.

[24]  Dawn B. Beaulieu,et al.  High-Throughput Multi-Analyte Luminex Profiling Implicates Eotaxin-1 in Ulcerative Colitis , 2013, PloS one.

[25]  J. Ward,et al.  The relationship between eosinophilia and airway remodelling in mild asthma , 2013, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[26]  E. King,et al.  Molecular diagnosis of eosinophilic esophagitis by gene expression profiling. , 2013, Gastroenterology.

[27]  A. Barski,et al.  IL-33 Markedly Activates Murine Eosinophils by an NF-κB–Dependent Mechanism Differentially Dependent upon an IL-4–Driven Autoinflammatory Loop , 2013, The Journal of Immunology.

[28]  R. Locksley,et al.  Type 2 innate lymphoid cells control eosinophil homeostasis , 2013, Nature.

[29]  Lisa J. Martin,et al.  High prevalence of eosinophilic esophagitis in patients with inherited connective tissue disorders. , 2013, The Journal of allergy and clinical immunology.

[30]  M. Halushka,et al.  TGFβ Receptor Mutations Impose a Strong Predisposition for Human Allergic Disease , 2013, Science Translational Medicine.

[31]  Q. Sattentau,et al.  Thymic stromal lymphopoietin–elicited basophil responses promote eosinophilic esophagitis , 2013, Nature Medicine.

[32]  Bart N Lambrecht,et al.  Cytokine targets in airway inflammation. , 2013, Current opinion in pharmacology.

[33]  M. Rothenberg,et al.  Eosinophil adoptive transfer system to directly evaluate pulmonary eosinophil trafficking in vivo , 2013, Proceedings of the National Academy of Sciences.

[34]  R. Locksley,et al.  Innate lymphoid type 2 cells sustain visceral adipose tissue eosinophils and alternatively activated macrophages , 2013, The Journal of experimental medicine.

[35]  K. Dyer,et al.  Eosinophils: changing perspectives in health and disease , 2012, Nature Reviews Immunology.

[36]  L. Denson,et al.  Intestinal CCL11 and Eosinophilic Inflammation Is Regulated by Myeloid Cell–Specific RelA/p65 in Mice , 2012, The Journal of Immunology.

[37]  S. Ziegler,et al.  The biology of thymic stromal lymphopoietin (TSLP). , 2013, Advances in pharmacology.

[38]  Kelley E. Capocelli,et al.  Local hypersensitivity reaction in transgenic mice with squamous epithelial IL-5 overexpression provides a novel model of eosinophilic oesophagitis , 2012, Gut.

[39]  E. Chilvers,et al.  Use of 111-Indium-labeled autologous eosinophils to establish the in vivo kinetics of human eosinophils in healthy subjects. , 2012, Blood.

[40]  N. Kawasaki,et al.  Siglec-8 as a drugable target to treat eosinophil and mast cell-associated conditions. , 2012, Pharmacology & therapeutics.

[41]  Ian D Pavord,et al.  Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial , 2012, The Lancet.

[42]  A. Viale,et al.  Familial transmission rather than defective innate immunity shapes the distinct intestinal microbiota of TLR-deficient mice , 2012, The Journal of experimental medicine.

[43]  James B. Young,et al.  Reslizumab in children and adolescents with eosinophilic esophagitis: results of a double-blind, randomized, placebo-controlled trial. , 2012, The Journal of allergy and clinical immunology.

[44]  C. Berek,et al.  Immunization induces activation of bone marrow eosinophils required for plasma cell survival , 2012, European journal of immunology.

[45]  Byung Soo Kim,et al.  Eosinophil Development, Regulation of Eosinophil-Specific Genes, and Role of Eosinophils in the Pathogenesis of Asthma , 2011, Allergy, asthma & immunology research.

[46]  L. Boulet,et al.  Reslizumab for poorly controlled, eosinophilic asthma: a randomized, placebo-controlled study. , 2011, American journal of respiratory and critical care medicine.

[47]  James J. Lee,et al.  CCR3 Blockade Attenuates Eosinophilic Ileitis and Associated Remodeling. , 2011, American Journal of Pathology.

[48]  Hergen Spits,et al.  Human IL-25- and IL-33-responsive type 2 innate lymphoid cells are defined by expression of CRTH2 and CD161 , 2011, Nature Immunology.

[49]  A. Chawla,et al.  Macrophage-mediated inflammation in metabolic disease , 2011, Nature Reviews Immunology.

[50]  A. Varki,et al.  Siglec-F Inhibition Reduces Esophageal Eosinophilia and Angiogenesis in a Mouse Model of Eosinophilic Esophagitis , 2011, Journal of pediatric gastroenterology and nutrition.

[51]  Nicola A Hanania,et al.  Lebrikizumab treatment in adults with asthma. , 2011, The New England journal of medicine.

[52]  E. Wherry,et al.  TSLP promotes interleukin-3-independent basophil haematopoiesis and type 2 inflammation , 2011, Nature.

[53]  T. Sentongo,et al.  Identification of Specific Foods Responsible for Inflammation in Children With Eosinophilic Esophagitis Successfully Treated With Empiric Elimination Diet , 2011, Journal of pediatric gastroenterology and nutrition.

[54]  M. Rothenberg,et al.  Colonic Eosinophilic Inflammation in Experimental Colitis Is Mediated by Ly6Chigh CCR2+ Inflammatory Monocyte/Macrophage-Derived CCL11 , 2011, The Journal of Immunology.

[55]  R. Locksley,et al.  Eosinophils Sustain Adipose Alternatively Activated Macrophages Associated with Glucose Homeostasis , 2011, Science.

[56]  J. Batra,et al.  Role of unique basic residues in cytotoxic, antibacterial and antiparasitic activities of human eosinophil cationic protein , 2011, Biological chemistry.

[57]  Reka Albert,et al.  Computational and Experimental Analysis Reveals a Requirement for Eosinophil-Derived IL-13 for the Development of Allergic Airway Responses in C57BL/6 Mice , 2011, The Journal of Immunology.

[58]  C. Berek,et al.  Eosinophils are required for the maintenance of plasma cells in the bone marrow , 2011, Nature Immunology.

[59]  C. Wong,et al.  Thymic stromal lymphopoietin induces chemotactic and prosurvival effects in eosinophils: implications in allergic inflammation. , 2010, American journal of respiratory cell and molecular biology.

[60]  G. Gleich,et al.  What targeting eosinophils has taught us about their role in diseases. , 2010, The Journal of allergy and clinical immunology.

[61]  Lisa J. Martin,et al.  Variants of thymic stromal lymphopoietin and its receptor associate with eosinophilic esophagitis. , 2010, The Journal of allergy and clinical immunology.

[62]  K. Kelleher,et al.  Serum IgE measurement and detection of food allergy in pediatric patients with eosinophilic esophagitis. , 2010, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[63]  Lisa J. Martin,et al.  Coordinate Interaction between IL-13 and Epithelial Differentiation Cluster Genes in Eosinophilic Esophagitis , 2010, The Journal of Immunology.

[64]  Joseph T. Glessner,et al.  Common variants at 5q22 associate with pediatric eosinophilic esophagitis , 2010, Nature Genetics.

[65]  P. Weller,et al.  Eosinophils as antigen-presenting cells in allergic upper airway disease , 2010, Current opinion in allergy and clinical immunology.

[66]  D. Broide,et al.  Resolution of remodeling in eosinophilic esophagitis correlates with epithelial response to topical corticosteroids , 2010, Allergy.

[67]  M. Teixeira,et al.  Gastrointestinal , Hepatobiliary and Pancreatic Pathology Treatment with a Novel Chemokine-Binding Protein or Eosinophil Lineage-Ablation Protects Mice from Experimental Colitis , 2010 .

[68]  A. Varki,et al.  Anti-Siglec-F Antibody Reduces Allergen-Induced Eosinophilic Inflammation and Airway Remodeling1 , 2009, The Journal of Immunology.

[69]  C. Beglinger,et al.  Anti-interleukin-5 antibody treatment (mepolizumab) in active eosinophilic oesophagitis: a randomised, placebo-controlled, double-blind trial , 2009, Gut.

[70]  Philippa Marrack,et al.  Alum Induces Innate Immune Responses through Macrophage and Mast Cell Sensors, But These Sensors Are Not Required for Alum to Act As an Adjuvant for Specific Immunity1 , 2009, The Journal of Immunology.

[71]  P. Gibson,et al.  Inflammatory phenotypes in adult asthma: clinical applications , 2009, The clinical respiratory journal.

[72]  M. Hayakawa,et al.  Mature interleukin-33 is produced by calpain-mediated cleavage in vivo. , 2009, Biochemical and biophysical research communications.

[73]  James J. Lee,et al.  Mouse Eosinophils Possess Potent Antibacterial Properties In Vivo , 2009, Infection and Immunity.

[74]  Marc E. Rothenberg,et al.  MicroRNA-21 Is Up-Regulated in Allergic Airway Inflammation and Regulates IL-12p35 Expression 1 , 2009, The Journal of Immunology.

[75]  Ana Sousa,et al.  Mepolizumab and exacerbations of refractory eosinophilic asthma. , 2009, The New England journal of medicine.

[76]  James J. Lee,et al.  Eosinophil Deficiency Compromises Parasite Survival in Chronic Nematode Infection1 , 2009, The Journal of Immunology.

[77]  K. Akashi,et al.  Identification of the human eosinophil lineage-committed progenitor: revision of phenotypic definition of the human common myeloid progenitor , 2009, The Journal of experimental medicine.

[78]  James J. Lee,et al.  Intestinal Macrophage/Epithelial Cell-Derived CCL11/Eotaxin-1 Mediates Eosinophil Recruitment and Function in Pediatric Ulcerative Colitis1 , 2008, The Journal of Immunology.

[79]  K. Legge,et al.  Cutting Edge: Eosinophils Do Not Contribute to Respiratory Syncytial Virus Vaccine-Enhanced Disease1 , 2008, The Journal of Immunology.

[80]  A. Straumann,et al.  Catapult-like release of mitochondrial DNA by eosinophils contributes to antibacterial defense , 2008, Nature Medicine.

[81]  M. Rothenberg,et al.  A dual activation and inhibition role for the paired immunoglobulin-like receptor B in eosinophils. , 2008, Blood.

[82]  A. August,et al.  Strain-specific requirement for eosinophils in the recruitment of T cells to the lung during the development of allergic asthma , 2008, The Journal of experimental medicine.

[83]  H. Kita,et al.  A novel IL-1 family cytokine, IL-33, potently activates human eosinophils. , 2008, The Journal of allergy and clinical immunology.

[84]  J. Molkentin,et al.  Periostin facilitates eosinophil tissue infiltration in allergic lung and esophageal responses , 2008, Mucosal Immunology.

[85]  P. Weller,et al.  Pivotal Advance: Eosinophils mediate early alum adjuvant‐elicited B cell priming and IgM production , 2008, Journal of leukocyte biology.

[86]  James J. Lee,et al.  Allergic pulmonary inflammation in mice is dependent on eosinophil-induced recruitment of effector T cells , 2008, The Journal of experimental medicine.

[87]  H. Rosenberg,et al.  Eosinophil-derived neurotoxin acts as an alarmin to activate the TLR2–MyD88 signal pathway in dendritic cells and enhances Th2 immune responses , 2008, The Journal of experimental medicine.

[88]  P. Weller,et al.  Eosinophils Mediate Early Alum Adjuvant-elicited B Cell Priming and IgM Production , 2008 .

[89]  N. Salzman,et al.  Enteric Salmonellosis Disrupts the Microbial Ecology of the Murine Gastrointestinal Tract , 2007, Infection and Immunity.

[90]  James J. Lee,et al.  Eosinophils act as antigen-presenting cells to induce immunity to Strongyloides stercoralis in mice. , 2007, The Journal of infectious diseases.

[91]  M. Vicario,et al.  IL-13 involvement in eosinophilic esophagitis: transcriptome analysis and reversibility with glucocorticoids. , 2007, The Journal of allergy and clinical immunology.

[92]  I. Ghiran,et al.  Airway Eosinophils: Allergic Inflammation Recruited Professional Antigen-Presenting Cells1 , 2007, The Journal of Immunology.

[93]  G. Cleghorn,et al.  Dichotomy of food and inhalant allergen sensitization in eosinophilic esophagitis , 2007, Allergy.

[94]  S. Gordon,et al.  EMR1, the human homolog of F4/80, is an eosinophil‐specific receptor , 2007, European journal of immunology.

[95]  S. Phipps,et al.  Eosinophils contribute to innate antiviral immunity and promote clearance of respiratory syncytial virus. , 2007, Blood.

[96]  S. Ackerman,et al.  Mechanisms of eosinophilia in the pathogenesis of hypereosinophilic disorders. , 2007, Immunology and allergy clinics of North America.

[97]  T. Colby,et al.  Coexpression of IL-5 and Eotaxin-2 in Mice Creates an Eosinophil-Dependent Model of Respiratory Inflammation with Characteristics of Severe Asthma1 , 2007, The Journal of Immunology.

[98]  K. McCoy,et al.  Use of axenic animals in studying the adaptation of mammals to their commensal intestinal microbiota. , 2007, Seminars in immunology.

[99]  D. Broide,et al.  Esophageal remodeling in pediatric eosinophilic esophagitis. , 2007, The Journal of allergy and clinical immunology.

[100]  R. Ramponi,et al.  Clinical applications , 2007, Lasers in Medical Science.

[101]  T. Sentongo,et al.  Effect of six-food elimination diet on clinical and histologic outcomes in eosinophilic esophagitis. , 2006, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[102]  M. Stolte,et al.  Eosinophil infiltration and degranulation in oesophageal mucosa from adult patients with eosinophilic oesophagitis: a retrospective and comparative study on pathological biopsy , 2006, Journal of Clinical Pathology.

[103]  B. Aronow,et al.  Eotaxin-3 and a uniquely conserved gene-expression profile in eosinophilic esophagitis. , 2006, The Journal of clinical investigation.

[104]  A. Fryer,et al.  Neuronal eotaxin and the effects of CCR3 antagonist on airway hyperreactivity and M2 receptor dysfunction. , 2005, The Journal of clinical investigation.

[105]  James J. Lee,et al.  Eosinophils alter colonic epithelial barrier function: role for major basic protein. , 2005, American journal of physiology. Gastrointestinal and liver physiology.

[106]  Nikolaos M. Nikolaidis,et al.  Identification of a Cooperative Mechanism Involving Interleukin-13 and Eotaxin-2 in Experimental Allergic Lung Inflammation* , 2005, Journal of Biological Chemistry.

[107]  F. Setién,et al.  Proteolytic Regulation of Activated STAT6 by Calpains1 , 2005, The Journal of Immunology.

[108]  A. Ghahary,et al.  Cutting Edge: Human Eosinophils Regulate T Cell Subset Selection through Indoleamine 2,3-Dioxygenase1 , 2004, The Journal of Immunology.

[109]  S. Kingsmore,et al.  Human Ribonuclease A Superfamily Members, Eosinophil-Derived Neurotoxin and Pancreatic Ribonuclease, Induce Dendritic Cell Maturation and Activation1 , 2004, The Journal of Immunology.

[110]  S. Orkin,et al.  A Critical Role for Eosinophils in Allergic Airways Remodeling , 2004, Science.

[111]  E. Lenkiewicz,et al.  Defining a Link with Asthma in Mice Congenitally Deficient in Eosinophils , 2004, Science.

[112]  P. Marrack,et al.  Promotion of B Cell Immune Responses via an Alum-Induced Myeloid Cell Population , 2004, Science.

[113]  J. Hampe,et al.  Quantification of Intestinal Bacterial Populations by Real-Time PCR with a Universal Primer Set and Minor Groove Binder Probes: a Global Approach to the Enteric Flora , 2004, Journal of Clinical Microbiology.

[114]  D. Broide,et al.  Inhibition of airway remodeling in IL-5-deficient mice. , 2004, The Journal of clinical investigation.

[115]  L. Palmer,et al.  Transforming growth factor-beta1 promoter polymorphism C-509T is associated with asthma. , 2004, American journal of respiratory and critical care medicine.

[116]  K. Dyer,et al.  Eosinophil-derived neurotoxin (EDN), an antimicrobial protein with chemotactic activities for dendritic cells. , 2003, Blood.

[117]  S. Phipps,et al.  Anti-IL-5 treatment reduces deposition of ECM proteins in the bronchial subepithelial basement membrane of mild atopic asthmatics. , 2003, The Journal of clinical investigation.

[118]  F. Mauny,et al.  Valeur de l’éosinopénie dans le diagnostic des syndromes inflammatoires : un « vieux » marqueur revisité , 2003 .

[119]  A. Nagler,et al.  Non-IgE-dependent activation of human lung- and cord blood-derived mast cells is induced by eosinophil major basic protein and modulated by the membrane form of stem cell factor. , 2003, Blood.

[120]  F. Mauny,et al.  [Value of eosinopenia in inflammatory disorders: an "old" marker revisited]. , 2003, La Revue de medecine interne.

[121]  F. Levi-Schaffer,et al.  Effects of eosinophils on mast cells: a new pathway for the perpetuation of allergic inflammation. , 2002, Molecular immunology.

[122]  P. Foster,et al.  Intrinsic Defect in T Cell Production of Interleukin (IL)-13 in the Absence of Both IL-5 and Eotaxin Precludes the Development of Eosinophilia and Airways Hyperreactivity in Experimental Asthma , 2002, The Journal of experimental medicine.

[123]  S. Orkin,et al.  Targeted Deletion of a High-Affinity GATA-binding Site in the GATA-1 Promoter Leads to Selective Loss of the Eosinophil Lineage In Vivo , 2002, The Journal of experimental medicine.

[124]  M. Rothenberg,et al.  IL-5 Promotes Eosinophil Trafficking to the Esophagus1 , 2002, The Journal of Immunology.

[125]  D. Friend,et al.  The murine CCR3 receptor regulates both the role of eosinophils and mast cells in allergen-induced airway inflammation and hyperresponsiveness , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[126]  M. Stone,et al.  NMR solution structure and backbone dynamics of the CC chemokine eotaxin-3. , 2001, Biochemistry.

[127]  J. Malm,et al.  Bactericidal Activity of Human Eosinophilic Granulocytes against Escherichia coli , 2001, Infection and Immunity.

[128]  M. Rothenberg,et al.  An etiological role for aeroallergens and eosinophils in experimental esophagitis. , 2001, The Journal of clinical investigation.

[129]  K. Chung,et al.  Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsìveness, and the late asthmatic response , 2000, The Lancet.

[130]  J. Grunewald,et al.  Increased interleukin-13 mRNA expression in bronchoalveolar lavage cells of atopic patients with mild asthma after repeated low-dose allergen provocations. , 2000, Respiratory medicine.

[131]  A. Balic,et al.  Do eosinophils have a role in the killing of helminth parasites? , 2000, Parasitology today.

[132]  M. Manns,et al.  Immunohistological assessment of intestinal eosinophil activation in patients with eosinophilic gastroenteritis and inflammatory bowel disease , 1999, American Journal of Gastroenterology.

[133]  I. Hirata,et al.  Fecal eosinophil granule-derived proteins reflect disease activity in inflammatory bowel disease , 1999, American Journal of Gastroenterology.

[134]  G. Gleich,et al.  Ovalbumin Sensitization Changes the Inflammatory Response to Subsequent Parainfluenza Infection , 1999, The Journal of experimental medicine.

[135]  Paige Lacy,et al.  Exocytotic events in eosinophils and mast cells , 1999, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[136]  M. Manns,et al.  Immunnohistological assessment of intestinal eosinophil activation in patients with eosinophilic gastroenteritis and inflammatory bowel disease. , 1999, The American journal of gastroenterology.

[137]  S. Bonini,et al.  Nerve growth factor is preformed in and activates human peripheral blood eosinophils. , 1998, The Journal of allergy and clinical immunology.

[138]  Lei Lu,et al.  Stem cell factor influences mast cell mediator release in response to eosinophil-derived granule major basic protein , 1998 .

[139]  K. Dyer,et al.  Recombinant human eosinophil-derived neurotoxin/RNase 2 functions as an effective antiviral agent against respiratory syncytial virus. , 1998, The Journal of infectious diseases.

[140]  D. Friend,et al.  Eotaxin is required for the baseline level of tissue eosinophils. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[141]  L. Lu,et al.  Stem cell factor influences mast cell mediator release in response to eosinophil-derived granule major basic protein. , 1998, Blood.

[142]  A. Fryer,et al.  Pretreatment with antibody to eosinophil major basic protein prevents hyperresponsiveness by protecting neuronal M2 muscarinic receptors in antigen-challenged guinea pigs. , 1997, The Journal of clinical investigation.

[143]  E. Rakasz,et al.  Lack of Fc-e Receptors on Murine Eosinophils: Implications for the Functional Significance of Elevated IgE and Eosinophils in Parasitic Infections , 1997 .

[144]  R. Martin,et al.  Expression of IL-12 and IL-13 mRNA in asthma and their modulation in response to steroid therapy. , 1997, American journal of respiratory and critical care medicine.

[145]  P. Foster,et al.  Relationship between interleukin-5 and eotaxin in regulating blood and tissue eosinophilia in mice. , 1997, The Journal of clinical investigation.

[146]  E. Rakasz,et al.  Lack of Fc-epsilon receptors on murine eosinophils: implications for the functional significance of elevated IgE and eosinophils in parasitic infections. , 1997, Blood.

[147]  N. Brattig,et al.  Serum levels of eosinophil cationic protein, eosinophil-derived neurotoxin and myeloperoxidase in infections with filariae and schistosomes. , 1996, Acta tropica.

[148]  T. Kotsimbos,et al.  Interleukin-13 and interleukin-4 are coexpressed in atopic asthma. , 1996, Proceedings of the Association of American Physicians.

[149]  J. Miyazaki,et al.  Defective B-1 cell development and impaired immunity against Angiostrongylus cantonensis in IL-5R alpha-deficient mice. , 1996, Immunity.

[150]  H. Rotman,et al.  Strongyloides stercoralis: eosinophil-dependent immune-mediated killing of third stage larvae in BALB/cByJ mice. , 1996, Experimental parasitology.

[151]  P. Hodgkin,et al.  IL-5-deficient mice have a developmental defect in CD5+ B-1 cells and lack eosinophilia but have normal antibody and cytotoxic T cell responses. , 1996, Immunity.

[152]  P. Scott,et al.  IL-4- and IL-5-dependent protective immunity to Onchocerca volvulus infective larvae in BALB/cBYJ mice. , 1994, Journal of immunology.

[153]  H. Dargie,et al.  A multicentre, double-blind, placebo-controlled trial of quinapril in mild, chronic heart failure. , 1993, European heart journal.

[154]  D. Jones.  The eosinophil. , 1993, Journal of comparative pathology.

[155]  M. Strath,et al.  Eosinophilia in transgenic mice expressing interleukin 5 , 1990, The Journal of experimental medicine.

[156]  T. Ganz,et al.  Antibacterial properties of eosinophil major basic protein and eosinophil cationic protein. , 1989, Journal of immunology.

[157]  B. Fields,et al.  Binding and transepithelial transport of immunoglobulins by intestinal M cells: demonstration using monoclonal IgA antibodies against enteric viral proteins , 1989, The Journal of cell biology.

[158]  Daniel Lucey,et al.  Mature human eosinophils have the capacity to express HLA-DR. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[159]  J. Tavernier,et al.  Killing of Plasmodium falciparum by eosinophil secretory products , 1987, Infection and immunity.

[160]  M. Yazdanbakhsh,et al.  Bactericidal action of eosinophils from normal human blood , 1986, Infection and immunity.

[161]  R. Sturrock,et al.  Observations on possible immunity to reinfection among Kenyan schoolchildren after treatment for Schistosoma mansoni. , 1983, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[162]  G. Gleich,et al.  Damage to Trichinella spiralis newborn larvae by eosinophil major basic protein. , 1979, The American journal of tropical medicine and hygiene.

[163]  D. Loegering,et al.  Damage to schistosomula of Schistosoma mansoni induced directly by eosinophil major basic protein. , 1979, Journal of immunology.

[164]  J. David,et al.  Antibody-dependent eosinophil-mediated damage to 51Cr-labeled schistosomula of Schistosoma mansoni: damage by purieid eosinophils , 1977, The Journal of experimental medicine.

[165]  D. A. Bass.  Behavior of eosinophil leukocytes in acute inflammation. II. Eosinophil dynamics during acute inflammation. , 1975, The Journal of clinical investigation.

[166]  M. Turner,et al.  Immune exclusion is a function of IgA , 1975, Nature.

[167]  W. H. Taliaferro,et al.  The Cellular Reactions in the Skin, Lungs and Intestine of Normal and Immune Rats afterInfection with Nippostrongylus Muris , 1939 .